Neuropsychiatric Disease and Treatment

Editor in Chief Dr Roger M Pinder

Role of pregabalin in the treatment of generalized anxiety disorder
David S Baldwin, Khalil Ajel

Clinical variables and implications of the personality on the outcome of bipolar illness: a pilot study
Nieves Casas-Barquero, Olga García-López, Pedro Fernández-Argüelles, Manuel Camacho-Laraña

Editorial: Treatment of generalized anxiety disorder || FREE PAPER ||
Roger M Pinder

Duloxetine in the treatment of major depressive disorder
David J Goldstein

Rivastigmine in the treatment of patients with Alzheimer’s disease
Thomas Müller

An alternative approach to measuring treatment persistence with antipsychotic agents among patients with schizophrenia in the Veterans Health Administration
Xinhua S Ren, Shirley Qian, Lewis E Kazis

Quetiapine in the treatment of schizophrenia
Michael Riedel, Norbert Müller, Martin Strassnig, Ilja Spellmann, Emanuel Severus, Hans-Jürgen Möller

The treatment of generalized anxiety disorder with pregabalin, an atypical anxiolytic
Jeffrey R Strawn, Thomas D Geracioti Jr

Glatiramer acetate in the treatment of multiple sclerosis
Alex Tselis, Omar Khan, Robert P Lisak

Memantine: efficacy and safety in mild-to-severe Alzheimer’s disease
Rajesh R Tampi, Christopher H van Dyck

Journal Indexing
See where all the Dove Press journals are indexed
Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio